Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner [NA]
A completed clinical trial evaluating interest in a self-sampling cervical cancer screening device provided by a general practitioner.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Improving Care for Rural Patients With Solid Tumors [NA]
Clinical trial update from University of Colorado focusing on improving care for rural patients with solid tumors; the study is currently re…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India
A multicenter implementation audit and resource assessment to evaluate compliance with cervical cancer chemoradiation guidelines across Indi…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies [Phase 1]
Phase 1 trial evaluating hyaluronic acid-based gel spacers in gynecologic malignancies, focusing on cervical cancer; recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
A clinical trial sponsored by Far Eastern Memorial Hospital examines the role of blood perfusion in cervical cancer, cervical intraepithelia…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer
A recruiting clinical study evaluating systemic and tumor immune responses during pelvic (chemo)radiation and/or brachytherapy for cervical …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity. [Phase 3]
This document describes a Phase 3 clinical trial evaluating whether oral sodium copper chlorophyllin, an NRF2 activator, can reduce late rad…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer [NA]
A clinical trial evaluating quality of life during radiotherapy for recurrent head and neck cancer has been withdrawn; the study also listed…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) [NA]
A prospective biobanking study by Institut Curie (SCANDARE) aims to understand how tumor molecular alterations relate to the tumor microenvi…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: The Effect of Motivational Interviewing on HPV-DNA Testing [NA]
The clinical trial evaluating whether motivational interviewing improves uptake of HPV-DNA testing for cervical cancer screening has complet…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
This clinical trial update outlines a prospective cohort study evaluating minimal residual disease testing to detect early recurrence in end…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer
This clinical trial update examines how dose and storage conditions of indocyanine green affect the efficacy and cost of sentinel lymph node…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial evaluating Lenti-HPV-07 immunotherapy for HPV-associated cervical cancer and HPV-positive orop…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
An ongoing clinical trial sponsored by Centre Paul Strauss is investigating the contribution of PET/MRI in locally advanced cervical cancer …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer [NA]
A clinical trial is evaluating the Q-Pad hrHPV test system for identifying precancerous cervical changes in individuals with HPV infection; …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]
First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of PHN-010 in Patients With Advanced Solid Tumors [Phase 1]
PHN-010 Phase 1 trial in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer [NA]
A clinical trial is validating a low-cost, lab-free screening test aimed at preventing cervical cancer; the study is currently recruiting.
-
EMA approval · 2026-01-28EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorised Abevmy (bevacizumab) as a biosimilar. It is approved for several cancer indications including colorectal, breast, ovarian, fa…
-
EMA approval · 2026-01-28EMA Authorised: Oyavas (bevacizumab) — STADA Arzneimittel AG
EMA authorised Oyavas, a bevacizumab biosimilar by STADA, for multiple indications including colorectal, breast, ovarian, fallopian tube, pe…
-
EMA approval · 2026-01-28EMA Authorised: Vegzelma (bevacizumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Vegzelma, a bevacizumab biosimilar from Celltrion Healthcare Hungary Kft., for multiple cancers including colorectal, breast,…
-
EMA approval · 2026-01-28EMA Authorised: Aybintio (bevacizumab) — Samsung Bioepis NL B.V.
The EMA authorised Aybintio, a bevacizumab biosimilar from Samsung Bioepis NL B.V., for multiple cancer indications including colorectal, br…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study [NA]
This is a pilot study evaluating an e-health Day-by-Day intervention to help manage Fear of Progression in women with stage III or IV gyneco…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 2]
Phase 2 trial update for HER3-DXd in locally advanced or metastatic solid tumors; the study is currently recruiting.